Issue 2020/01
March, 2020
Dear customers, dear friends,
What to do when the world is trapped by COVID-19?
We live in unpredictable times; this is for sure! Everything is floating due to COVID-19. The situation is changing locally as well as globally every minute, and sometimes even dramatically. As never before in human history, our health is in the focus of attention.

Find out more
Visiting Phyllyps Medical Diagnostics
In January, Christophe Bayet visited our distributor Phyllyps Medical Diagnostics in Ghana and reported the following positive feedback.

Find out more
DiaSys India awarded a TÜV SÜD certificate
DiaSys India has been awarded the EN ISO13485:2016 QMS certificate on February 10, 2020, for its Mahape, Navi Mumbai facility.

Find out more
Capacity expansion of the production facility
The intended plant expansion is now in progress. The process involves an enlargement of the filling department, the construction of a new filling plant, moving office spaces for departments, such as the facility management and the introduction of a new three-shift operation system.

Find out more
 Procalcitonin FS - The reliable alternative when time matters.
Serum Procalcitonin (PCT) levels are a sensitive marker for severe and systemic bacterial infections. In healthy individuals, PCT is primarily produced in thyroid C cells as a precursor to calcitonin, a calcium-regulating hormone.

Find out more
 Importance of preconceptional diabetes control!
Pregnancies in women with known diabetes (type I and II) are associated with high risk. Pregnancy should only be planned when the optimal metabolic conditions are met.

Find out more
 2019 ESC/EAS guidelines for dyslipidemia management
New guidelines for management of dyslipidemia: lipid modification to reduce cardiovascular risks, were published in August 2019 by the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Find out more
 Lipase for early diagnosis of post-ERCP pancreatitis
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that uses X-rays to view the patient's bile and pancreatic ducts.

Find out more
 HbA1c-Strong predictor of recurrent cardiovascular disease (CVD) events
According to a study published in January 2020 in Diabetes Care, intensive glucose management in adults with type 1 diabetes avoids an initial or subsequent cardiovascular disease or major adverse cardiovascular disease event.

Find out more
 State of play-The implementation of new In Vitro Diagnostic Regulation
With this overview, we would like to give you all relevant information about the general In Vitro Diagnostic Regulation (IVDR) implementation status and state of play at DiaSys.

Find out more
 Promotional tools
To support your local product marketing, the following promotional material was published.

Find out more
Medlab Middle East 2020 was a great success
Four intensive days, countless meetings, and interesting encounters at the world's largest and most important trade fair in the laboratory and diagnostics sector are behind us.

Find out more
If you have any questions or suggestions please contact:

Executive board:
Dr. Günther Gorka,
Dr. Jan Gorka,
Peter Zöller
DiaSys Diagnostic Systems GmbH
Alte Strasse 9 | 65558 Holzheim | DE

Fon: +49 (0) 64 32 - 91 46-0
Fax: +49 (0) 64 32 - 91 46-32
Register court: AG Montabaur
Registration number: HRB 7106

Sales tax identification number according to
§ 27 a VAT registration number: DE 148-404-658